Mycobacterium arupense
Mycobacterium arupense | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Scientific classification | ||||||||||||||
| ||||||||||||||
Binomial name | ||||||||||||||
Mycobacterium arupense Cloud et al. 2006, ATCC BAA-1242 |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Mycobacterium arupense is a rapidly growing mycobacterium first isolated from soil and human sputum samples in Spain. Etymology: arupense, pertaining to the ARUP Institute for Clinical and Experimental Pathology, where the type strain was characterized.
Description
Microscopy
- Gram-positive, nonmotile and acid-fast rods (1-3µm x 0.5-0.7µm), mostly strong acid-fast.
Colony characteristics
- Colonies are eugonic, rough and nonpigmented.
Physiology
- Colonies occur within 5 days at 30°C (optimum temperature, no growth at 45°C) on Löwenstein-Jensen medium and on Middlebrook 7H10 agar.
- No growth on MacConkey agar without crystal violet.
- The type strain is resistant to D-cycloserine, streptomycin, isoniazid (0.1 and 1 mg/l), rifampin, and thiacetazone and is susceptible to isoniazid (10 mg/l), kanamycin, and capreomycin.
Pathogenesis
- Not associated with disease.
Type Strain
- First isolated from water samples, from soil and human sputum samples, Spain.
- Strain AR30097 = ATCC BAA-1242 = DSM 44942.
References
- CLOUD (J.L.), MEYER (J.J.), POUNDER (J.I.), JOST Jr. (K.C.), SWEENEY (A.), CARROLL (K.C.) and WOODS (G.L.): Mycobacterium arupense sp. nov., a non-chromogenic bacterium isolated from clinical specimens. Int. J. Syst. Evol. Microbiol., 2006, 56, 1413-1418.
de:Mycobacterium arupense
nl:Mycobacterium arupense
Template:SIB